This website uses cookies to enhance the user experience.
||
B

BIOSENROH AS928 705 161

Research
Limited company
c/o Erik Hornes Lilleakerveien 9 0283 OSLO, Norge

BIOSENROH AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
Years since formation
3 years
since Feb 9, 2022
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
30,000
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2024
226,284
NOK
Annual total result 2024
156,793
NOK
Total equity 2024
30,000
NOK
Last update: Aug 4, 2025

Management

Board

NameRoleShares
Chairman
100 %
directly

Top 10 individual shareholders

NameRoleShares
Chairman
100 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
30,000
100 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year202420232022
Total operating income
226,284
299,726
379,200
Annual Total Result
156,793
188,746
251,069
Total assets
236,586
539,467
374,339
Total liabilities
206,586
266,416
343,270
Total equity
30,000
273,051
31,069

P&L

Year202420232022
Total operating income
226,284
299,726
379,200
Total operating costs
25,643
56,810
57,317
Operating result
200,641
242,916
321,883
Financial income/costs
376
-934
0
Profit before tax
201,017
241,982
321,883
Total tax & extraordinary income/cost
44,224
53,236
70,814
Annual Total Result
156,793
188,746
251,069

Balance overview

Year202420232022
Total fixed assets
0
0
0
Total current assets
236,586
539,467
374,339
Total assets
236,586
539,467
374,339
Short term debt
201,017
10,846
337,700
Long term debt
5,570
255,570
5,570
Total liabilities
206,586
266,416
343,270
Contributed capital
30,000
30,000
30,000
Retained earnings
0
243,051
1,069
Total equity
30,000
273,051
31,069
Total equity and liabilities
236,586
539,467
374,339

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology